Literature DB >> 19255797

Plasma LCAT activity and lipid subfraction composition in obese beagles undergoing weight loss.

Rebecca Angell1, Yuka Mitsuhashi, Karen Bigley, John E Bauer.   

Abstract

The relationship between lecithin:cholesterol acyltransferase (LCAT) activity and weight loss in dogs was investigated. Four experimental weight-loss diets were fed to 12 obese female beagles for 56 days in a partial crossover design (n = 6). High- (HGI) or low- (LGI) glycemic index starch and diacylglycerol or triacylglycerol oils were combined to compose experimental diets with similar fatty acid profiles. Food intake and body weights were measured daily and weekly, respectively. Fasted blood samples were drawn at day 0, day 28, and day 56 to measure plasma LCAT activity and total (TC), unesterified (UC), and esterified (EC) cholesterol concentrations, and for fatty acid analysis of the phospholipid (PL) and EC fractions. The LGI groups lost more weight than the HGI groups due to starch digestibility differences. An HGI starch effect on TC and UC concentrations was observed but was unrelated to weight loss. LCAT activities increased over time but were not different after controlling for percentage weight loss. However, a positive linear correlation was found between LCAT and UC concentrations in all groups. Plasma PL fatty acid profiles reflected the diets fed, but increases in 16 and 18 carbon saturated and monounsaturated fatty acids in all groups appeared to be an effect of fatty acid mobilization from storage sites. Both plasma PL and EC fatty acid profiles were similar with both acylglycerol types and EC fatty acids reflected linoleic acid specificity with minimal diet or time effects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19255797     DOI: 10.1007/s11745-009-3290-x

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  24 in total

Review 1.  Understanding and managing obesity in dogs and cats.

Authors:  Dottie P Laflamme
Journal:  Vet Clin North Am Small Anim Pract       Date:  2006-11       Impact factor: 2.093

2.  Prevalence of obesity in dogs examined by Australian veterinary practices and the risk factors involved.

Authors:  P D McGreevy; P C Thomson; C Pride; A Fawcett; T Grassi; B Jones
Journal:  Vet Rec       Date:  2005-05-28       Impact factor: 2.695

3.  Effects of obesity on lipid profiles in neutered male and female cats.

Authors:  Margarethe Hoenig; Caroline Wilkins; Jennifer C Holson; Duncan C Ferguson
Journal:  Am J Vet Res       Date:  2003-03       Impact factor: 1.156

4.  Digestion and assimilation features of dietary DAG in the rat small intestine.

Authors:  Hidehiko Kondo; Tadashi Hase; Takatoshi Murase; Ichiro Tokimitsu
Journal:  Lipids       Date:  2003-01       Impact factor: 1.880

5.  Influence of obesity on plasma lipid and lipoprotein concentrations in dogs.

Authors:  Isabelle C Jeusette; Estelle T Lhoest; Louis P Istasse; Marianne O Diez
Journal:  Am J Vet Res       Date:  2005-01       Impact factor: 1.156

6.  Specificity of lecithin:cholesterol acyltransferase and atherogenic risk: comparative studies on the plasma composition and in vitro synthesis of cholesteryl esters in 14 vertebrate species.

Authors:  M Liu; J D Bagdade; P V Subbaiah
Journal:  J Lipid Res       Date:  1995-08       Impact factor: 5.922

7.  Lecithin:cholesterol acyltransferase (LCAT) mass; its relationship to LCAT activity and cholesterol esterification rate.

Authors:  J J Albers; C H Chen; J L Adolphson
Journal:  J Lipid Res       Date:  1981-11       Impact factor: 5.922

8.  Stereospecificity of monoacylglycerol and diacylglycerol acyltransferases from rat intestine as determined by chiral phase high-performance liquid chromatography.

Authors:  R Lehner; A Kuksis; Y Itabashi
Journal:  Lipids       Date:  1993-01       Impact factor: 1.880

9.  Re-induction of obese body weight occurs more rapidly and at lower caloric intake in beagles.

Authors:  D Nagaoka; Y Mitsuhashi; R Angell; K E Bigley; J E Bauer
Journal:  J Anim Physiol Anim Nutr (Berl)       Date:  2009-03-31       Impact factor: 2.130

10.  Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation.

Authors:  Cassandra E Forsythe; Stephen D Phinney; Maria Luz Fernandez; Erin E Quann; Richard J Wood; Doug M Bibus; William J Kraemer; Richard D Feinman; Jeff S Volek
Journal:  Lipids       Date:  2007-11-29       Impact factor: 1.880

View more
  5 in total

1.  Plasma lipid profiling in a large population-based cohort.

Authors:  Jacquelyn M Weir; Gerard Wong; Christopher K Barlow; Melissa A Greeve; Adam Kowalczyk; Laura Almasy; Anthony G Comuzzie; Michael C Mahaney; Jeremy B M Jowett; Jonathan Shaw; Joanne E Curran; John Blangero; Peter J Meikle
Journal:  J Lipid Res       Date:  2013-07-18       Impact factor: 5.922

Review 2.  Obesity Genomics and Metabolomics: a Nexus of Cardiometabolic Risk.

Authors:  Jessica A Regan; Svati H Shah
Journal:  Curr Cardiol Rep       Date:  2020-10-10       Impact factor: 2.931

3.  Localization of fatty acyl and double bond positions in phosphatidylcholines using a dual stage CID fragmentation coupled with ion mobility mass spectrometry.

Authors:  Jose Castro-Perez; Thomas P Roddy; Nico M M Nibbering; Vinit Shah; David G McLaren; Stephen Previs; Athula B Attygalle; Kithsiri Herath; Zhu Chen; Sheng-Ping Wang; Lyndon Mitnaul; Brian K Hubbard; Rob J Vreeken; Douglas G Johns; Thomas Hankemeier
Journal:  J Am Soc Mass Spectrom       Date:  2011-06-24       Impact factor: 3.109

4.  The effect of weight loss on HDL subfractions and LCAT activity in two genotypes of APOA-II -265T>C polymorphism.

Authors:  Masoumeh Moradi; Maryam Mahmoudi; Ahmad Saedisomeolia; Roxana Zahirihashemi; Fariba Koohdani
Journal:  Nutr J       Date:  2017-05-25       Impact factor: 3.271

5.  Lipidomic Profile Revealed the Association of Plasma Lysophosphatidylcholines with Adolescent Obesity.

Authors:  Yang Wang; Chang-Tao Jiang; Jie-Yun Song; Qi-Ying Song; Jun Ma; Hai-Jun Wang
Journal:  Biomed Res Int       Date:  2019-12-13       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.